Dr. Katzeff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
44 Jackson Rd
Mahopac, NY 10541Phone+1 914-262-7900Fax+1 925-307-5216
Education & Training
University of Vermont Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1979 - 1982
University of Arizona College of Medicine-PhoenixResidency, Internal Medicine, 1976 - 1979
State University of New York Downstate Medical Center College of MedicineClass of 1976
Certifications & Licensure
NY State Medical License 1982 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 18 citationsUrinary albumin excretion with sitagliptin compared to sulfonylurea as add on to metformin in type 2 diabetes patients with albuminuria: A real-world evidence studyInbal Goldshtein, Avraham Karasik, Cheli Melzer-Cohen, Samuel S. Engel, Shengsheng Yu
Journal of Diabetes and Its Complications. 2016-09-01 - 3 citationsLong-term efficacy of sitagliptin as either monotherapy or add-on therapy to metformin: improvement in glycemic control over 2 years in patients with type 2 diabetes.Harvey L Katzeff, D. E. Williams-Herman, Lei Xu, Gregory T. Golm, H. Wang
Current Medical Research and Opinion. 2015-04-08 - 55 citationsHypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study.S R Aravind, Shaiful Bahari Ismail, R Balamurugan, Jugal Bihari Gupta, Tarun Wadhwa
Current Medical Research and Opinion. 2012-06-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
